DNA virus Epstein-Barr trong huyết thanh sau khi ghép gan — giám sát hoạt động virus trong quá trình điều trị bằng các tác nhân ức chế miễn dịch khác nhau

Barkholt L, Billing H, Juliusson G, Porwit A, Ericzon BG, Groth CG (1991) B-cell lymphoma in transplanted liver. Clinical, histological and radiological manifestations. Transpl Int 4: 8–11 Barkholt L, Ericzon B-G, Tollemar J, Malmborg A-S, Ehrnst A, Wilczek H, Andersson J (1993) Infections in human liver recipients: different patterns early and late after transplantation. Transpl Int 6: 77–84 Bryttinger M, Xu W, Wahren B, Sundqvist V (1992) Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections. J Clin Microbiol 30: 1937–1941 Burman K, Crawford DH (1991) Effect of FK506 on Epstein-Barr virus specific cytotoxic T-cells. Lancet 337: 297–298 Cinque P, Brytting M, Vago L, Castagna A, Parravicini C, Zanchetta N, Manforte AA, Wahren B, Lazzarin A, Linde A (1993) Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 342: 398–401 Cohen KI (1991) Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Proc Natl Acad Sci USA 86: 9558–9561 Crawford DH, Edwards JMB, Sweny P, Janossy G, Hoffbrand AV (1981) Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet I: 10–12 European FK506 multicenter liver study group (1994) Randomised trial comparing Tacrolimus (FK506) and Cyclosporin in prevention of liver allograft rejection. Lancet 344: 423–428 Ferry JA, Jacobson JO, Conti D, Delmonico F, Harris NL (1989) Lymphoproliferative disorders and hematologic malignancies following organ transplantation. Mod Pathol 2: 583–592 Gan Y-J, Sullivan JL, Sixbey JW (1994) Detection of cell-free Epstein-Barr virus DNA in serum during active infectious mononucleosis. J Infect Dis 170: 436–439 Hara K, Kohno S, Koga H, Kaku M, Tomono K, Sakata S, Komatsu K, Omagari K (1995) Infections in patients with liver cirrhosis and hepatocellular carcinoma. Intern Med 34: 491–495 Jawetz E, Melnick JL, Adelberg EA (1991) Herpes virues. In: Jawetz E, Melnick JL, Adelberg EA (eds) Medical microbiology. Prentice-Hall International, East Norwalk, Connecticut, pp 418–440 Levine PH, Ebbesen P, Ablashi DV, Saxiner WC, Nordentoft A, Connelly R (1992) Antibodies to human herpes virus-6 and clinical course in patients with Hodgkin's disease. Int J Cancer 51: 53–57 Linde A, Andersson J, Lundgren G, Wahren B (1987) Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections. J Med Virol 21: 109–121 Linde A, Kallin B, Dillner J, Andersson J, Jägdahl L, Lindvall A, Wahren B (1990) Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis. J Infect Dis 161: 903–909 Marsano L, Perillo RP, Flye MW, Hanto DW, Soitzer ED, Thomas JR, Murray PR, Windus DW, Brant EM, Storch GA (1990) Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipients. J Infect Dis 161: 454–461 Masucci MG, Ernberg I (1994) Epstein-Barr virus: adaptation to a life within the immune system. Trends Microbiol Rev 2: 125–130 McDiarmid SV, Busuttil RW, Levy P, Millis MJ, Terasaki PI, Ament ME (1991) The long-term outcome of OKT3 compared with cyclosporin prophylaxis after liver transplantation. Transplantation 52: 91–97 Nalesnik MA, Makowka L, Starzl TE (1988) Diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg 25: 365–472 Nyberg G, Bergström T, Blohmé I, Nordén G, Olofsson S, Ricksten A (1994) Clinical evaluation in organ transplant patients of a polymerase chain reaction test for CMV DNA applied on white cells and serum. Transpl Int 7: 428–433 Penn I (1993) Epstein-Barr virus-associated disorders in transplant patients. Literature Scan Transplant 9: 30–32 Randhawa PS, Markin RS, Starzl TE, Demetris AJ (1990) Epstein-Barr virus-associated syndromes after liver transplantation. Am J Surg Pathol 14: 538–547 Rasmussen L, Kelsall D, Nelson R, Carney W, Hirsch M, Winston D, Preiksaitis J, Merigan TC (1982) Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects with cytomegalovirus. J Infect Dis 2: 191–199 Rea D, Fourcade C, Leblond V, Rowe M, Joab I, Edelman L, Bitker MO, Ganbdjbakhch I, Suberbielle C, Farcet JP, Raphael M (1994) Patterns of Epstein-Barr virus latent and proliferative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. Transplantation 58: 317–324 Renard TH, Andrews WS, Foster ME (1991) Relationship between OKT3 administration, EBV seroconversion, and the lymphoproliferative syndrome in pediatric liver transplant recipients. Transplant Proc 23: 1473–1476 Rooney CM, Loftin SK, Holladay MS, Brenner MK, Krance RA, Heslop HE (1995) Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br J Haematol 89: 98–103 Secchiero P, Carrigan DR, Asano Y, Benedetti L, Crowley RW, Komaroff AL, Gallo RC, Lusso P (1995) Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 171: 273–280 Singh N, Gayowski T, Wagener M, Yu VL (1994) Infectious complications in liver transplant recipients on Tacrolimus. Transplantation 58: 774–778 Snover DC, Freece DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL (1987) Liver allograft rejection: an analysis of the use of biopsy in determining the outcome of rejection. Am J Surg Pathol 11: 1–10 Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, Rosenthal JT, Hakala TR, Shaw BW Jr, Hardesty RL, Atchison RW, Jaffe R, Bahnson HT (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet I: 583–587 Svedmyr E, Ernberger I, Seeley J, Weiland O, Masucci G, Tsukuda K, Szigeti R, Masucci MG, Blomgren H, Berthold W, Henle W, Klein G (1984) Virologic, immunologic, and clinical observations on a patient during the incubation, acute and convalescent phases of infectious mononucleosis. Clin Immunol Immunopathol 30: 437–450 Swinnen LJ, Costanzo-Nordin MR, Fisher SG, O'Sullivan EJ, Johnson MR, Heroux AL, Dizikes GJ, Pifarre R, Fisher RI (1990) Increased incidence of lymphoproliferative disorders after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 323: 1723–1728 Telenti A, Smith TD, Ludwig F, Keating MR, Krom RAF, Wiesner RH (1991) Epstein-Barr virus and persistent graft dysfunction after liver transplantation. Hepatology 14: 282–286 The U.S. Multicenter FK506 Liver Study Group (1994) A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 331: 1110–1115 1994 Annual Report of the U.S. Scientific Registry for Transplantation Recipients and the Organ Procurement and Transplantation Network—Transplant Data, 1988–1993. UNOS Richmond, VA and the Division of Organ Transplantation, Bureau of Health Resources Development, Health Resources and Services Administration, U.S. Department of Health and Human Services, Bethesda, MD, USA